These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4347473)

  • 1. Enhanced responses to tyramine and angiotensin produced by 4,4'-biphenylene bis-((2-oxoethylene)-bis-(2,2-diethoxylethyl)dimethylammonium bromide) (DMAE).
    Greenberg S; Long JP
    Eur J Pharmacol; 1971 Jun; 15(1):15-22. PubMed ID: 4347473
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 4,4'-biphenylene-bis-(2-oxoethylene)-bis-(2,2-diethoxyethyl) dimethylammonium dibromide (DMAE) on catecholamines released by angiotensin.
    Greenberg S; Kadowitz PJ; Long JP
    Eur J Pharmacol; 1972 Jan; 17(1):59-65. PubMed ID: 4335850
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation by [4,4'-biphenylenebis(2-oxoethylene)]bis-[2,2-diethoxyethyl) dimethylammonium bromide] (DMAE) of the sympathetic component of the vasopressor response to angiotensin.
    Greenberg S; Long JP
    J Pharmacol Exp Ther; 1970 Jul; 174(1):35-44. PubMed ID: 4316535
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of (4,4'-biphenylene-bis-(2-oxoethylene))-bis-((di-2-ethoxyethyl) methylammonium bromide) "DEO".
    Chiou CY; Long JP; Greenberg S; Shriver DA
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):29-42. PubMed ID: 4262838
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of 4,4'-biphenylenebis-((2-oxoethylene)-bis-(2,2-diethoxyethyl))dimethylammonium dibromide (DMAE) on the responses of tissues innervated by short adrenergic neurons to catecholamines and ionic stimulants.
    Greenberg S; Long JP; Diecke FP
    J Pharmacol Exp Ther; 1971 Nov; 179(2):161-70. PubMed ID: 4332323
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction between angiotensin and neurally released norepinephrine on the cat nictitating membrane in vivo.
    Cervoni P; Reit E
    J Pharmacol Exp Ther; 1971 Dec; 179(3):543-54. PubMed ID: 4332751
    [No Abstract]   [Full Text] [Related]  

  • 7. The onset of denervation supersensitivity.
    Langer SZ; Trendelenburg U
    J Pharmacol Exp Ther; 1966 Jan; 151(1):73-86. PubMed ID: 5902181
    [No Abstract]   [Full Text] [Related]  

  • 8. Response of the nictitating membrane to prostaglandin E1 and angiotensin.
    Türker RK; Khairallah PA; Kayaalp SO; Kaymakcalan S
    Eur J Pharmacol; 1969 Jan; 5(2):173-9. PubMed ID: 4305655
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin-induced contraction of the cat nictitating membrane.
    Block AJ; Cervoni P; Reit E
    Eur J Pharmacol; 1971 Jun; 15(1):23-8. PubMed ID: 4347474
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of noradrenaline in the acute pressor response to angiotensin in conscious cats.
    Day MD; Owen DA
    Br J Pharmacol; 1970 Dec; 40(4):884-5. PubMed ID: 4322044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phentolamine on responses of the normal and of the denervated nictitating membrane of the pithed cat to tyramine.
    Hoszowska-Owczarek A
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):9-25. PubMed ID: 4390922
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of adrenal medullary responses to angiotensin by (4,4'-biphenylenebis-(2-oxoethylene)) bis((2,2-diethoxyethyl)-dimethylammonium bromide) (DMAE) in vitro.
    Peach MJ; Westfall TC
    J Pharmacol Exp Ther; 1972 Jun; 181(3):472-8. PubMed ID: 4338174
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tyramine tachyphylaxis; its recovery and interaction with enzyme inhibitors in arterial pressure and cat nictitating membrane].
    Lorenzo Fernandez P; Moreno A; Mediavilla A; Navas J
    Arch Inst Farmacol Exp (Madr); 1969; 21(1):11-42. PubMed ID: 4328437
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of ganglionic denervation supersensitivity using McN-A-343 and histamine as ganglion stimulating agents.
    Brezenoff HE; Gertner SB
    Proc Soc Exp Biol Med; 1969 Apr; 130(4):1229-33. PubMed ID: 5780005
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of amantadine with tyramine and noradrenaline on the cat nictitating membrane.
    Sinclair JG
    Can J Physiol Pharmacol; 1973 Apr; 51(4):305-8. PubMed ID: 4701722
    [No Abstract]   [Full Text] [Related]  

  • 16. Some direct and indirect sympathomimetic actions of metaraminol.
    Stone CA; Stavorski JM; Ludden CT; Wenger HC; Torchiana ML
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):49-60. PubMed ID: 5941882
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of beta-TM 10 on the pharmacological, biochemical and morphological changes induced by denervation of the nictitating membrane in the cat.
    Pluchino S; Van Orden LS; Draskóczy PR; Langer SZ; Trendelenburg U
    J Pharmacol Exp Ther; 1970 Mar; 172(1):77-90. PubMed ID: 5416947
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation of venoconstriction by alpha,alpha'-bis-(dimethylammoniumacetaldehyde diethylacetal)-p,p'-diacetylbiphenyl dibromide, DMAE.
    Wong S; Gross EG; Long JP
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):177-84. PubMed ID: 4311059
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction between angiotensin and bloodborne exogenous norepinephrine on the cat nictitating membrane in vivo.
    Cervoni P; Reit E
    J Pharmacol Exp Ther; 1971 Jun; 177(3):633-40. PubMed ID: 4328020
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of angiotensin with exogenous and neurally released norepinephrine on the cat nictitating membrane in vitro.
    Cervoni P; Reit E
    J Pharmacol Exp Ther; 1975 Jul; 194(1):1-8. PubMed ID: 1151742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.